FIELD: medicine.
SUBSTANCE: method is ensured as follows. During 30 days, a patient takes orally probiotic Sporobacterin dosed 1 ml twice a day. Said therapeutic course is repeated every six months.
EFFECT: method provides increase in number of T-helpers according to the trend of immunoregulating coefficient CD4/CD8 of HIV-positive patients.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING HIV-INFECTED PATIENTS | 2003 |
|
RU2237484C1 |
| METHOD OF TREATING EPSTEIN-BARR VIRAL INFECTION IN HIV-INFECTED CHILDREN | 2014 |
|
RU2555474C1 |
| METHOD OF PREDICTING EFFICIENCY OF ANTIRETROVIRAL THERAPY IN CASE IN HIV-INFECTION | 2009 |
|
RU2414858C1 |
| COMPOSITIONS AND METHODS FOR APPLYING PHORBOL ESTERS | 2008 |
|
RU2472511C2 |
| METHOD OF TREATING CHRONIC DISEASES OF EAR-NOSE-THROAT ORGANS WITH VIRAL, BACTERIAL, AND MIXED VIRAL-BACTERIAL ETIOLOGY IN HIV-INFECTED CHILDREN AND ADOLESCENTS | 2004 |
|
RU2305558C2 |
| METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
| DRUG FOR HIV-INFECTION TREATMENT | 2007 |
|
RU2379049C2 |
| CCR5 ANTAGONIST FOR ENHANCING IMMUNORESTORATIVE THERAPY AND TREATMENT OF OPPORTUNISTIC INFECTION IN PATIENTS WITH HIV | 2007 |
|
RU2420284C2 |
| LIQUID PREPARATION SPOROBACTERIN | 2001 |
|
RU2217154C2 |
| METHOD AND COMPOSITION FOR PREVENTING HIV INFECTION, PREVENTING AND TREATING HIV-CAUSED OR HIV-ASSOCIATED DISEASES, INCLUDING AIDS | 2010 |
|
RU2516931C2 |
